In this special episode, Drs. Carla Marienfeld, Marcela Smid, Tanner Wright, and Ljuba Mirsky, discuss the emerging concept of fetal fentanyl syndrome.

In this episode of Beyond The Abstract, Dr. Kathleen Adams stops by to talk about her new article Low-dose Buprenorphine Initiation in Pregnancy: A Systematic Review featured in the May/June issue of the Journal of Addiction Medicine.

Article Link: Low-dose Buprenorphine Initiation in Pregnancy: A Systematic Review

In today's Episode Rewind, we're revisiting our interview with Dr. Emily Pasman. Dr. Pasman talks about her article Nonabstinence Among US Adults in Recovery From an Alcohol or Other Drug Problem. She discusses the findings from her study as well as the potential limitations of using a solely abstinence-focused treatment and recovery model for addiction care.

Emily Pasman is a licensed social worker and postdoctoral research fellow at the University of Michigan Center for the Study of Drugs, Alcohol, Smoking, and Health. Her research aims to improve health equity for people who use drugs by expanding harm reduction interventions; supporting affected family members; and addressing disparities in service access, uptake, and outcomes. Grounded in her practice background in peer-delivered services, she uses participatory methods to engage people with lived and living experience in all aspects of the research process.

-

Article Link: Nonabstinence Among US Adults in Recovery From an Alcohol or Other Drug Problem

In this episode of Beyond The Abstract, Dr. Manish Jha stops by to talk about his new article Craving, Impulsivity, and Subsequent Methamphetamine Use With Naltrexone-Bupropion Versus Placebo: Findings From a Randomized Clinical Trial featured in the March/April issue of the Journal of Addiction Medicine.

Article Link: Craving, Impulsivity, and Subsequent Methamphetamine Use With Naltrexone-Bupropion Versus Placebo: Findings From a Randomized Clinical Trial

In this episode of Beyond The Abstract, Dr. Phil Durney and Dr. Kory London stop by the show to discuss their latest article featured in the current March/April issue of the Journal of Addiction Medicine titled Severe Fentanyl Withdrawal Associated With Medetomidine Adulteration: A Multicenter Study From Philadelphia, PA.

They discuss what medetomidine is, how it functions, and how its emergence in the fentanyl supply is impacting the opioid crisis in the US, as well as clinical management of medetomidine exposure and withdrawal in hospital and outpatient settings.

Article Link: Severe Fentanyl Withdrawal Associated With Medetomidine Adulteration: A Multicenter Study From Philadelphia, PA

In this episode, Dr. Nabila El-Bassel stops by the show to discuss her new research article Artificial Intelligence and Stigma in Addiction Research: Insights From the HEALing Communities Study Coalition Meetings, featured in the March/April 2026 issue of the Journal of Addiction Medicine.

Article Link: Addiction Research: Insights From the HEALing Communities Study Coalition Meetings

In this episode, Dr. Jasmine Barnes and Dr. Margaret Lowenstein sit down to discuss their new article Characterization of a Young Adult Sample Accessing Buprenorphine Via Telehealth in Philadelphia, PA featured in the January/February 2026 issue of the Journal of Addiction Medicine.

Article Link: Characterization of a Young Adult Sample Accessing Buprenorphine Via Telehealth in Philadelphia, PA

In today's Episode Rewind we're revisiting our interview with Dr. Marcela Smid, live at the 56th Annual ASAM Conference in Denver. Dr. Smid sits down to discuss article submissions and peer review, as well as demystifying the scientific publishing process for new authors.

Learn more about this year's upcoming conference in San Diego, CA > https://bit.ly/3OTOx79 

In this episode of Beyond The Abstract, Dr. Matthew Sloan sits down to discuss findings from his recent article Symptom-Triggered Alcohol Withdrawal Management Delivered Over Telemedicine featured in the November/December issue of the Journal of Addiction Medicine. Join us as Dr. Sloan shares insights into his study investigating the feasibility of delivering symptom-triggered alcohol withdrawal management over telemedicine.

Dr. Matthew Sloan is a clinician scientist at the Centre for Addiction and Mental Health in Toronto, Ontario, Canada. He specializes in the treatment of substance use disorders and their psychiatric comorbidities. He completed medical school and psychiatry residency at McGill University followed by a postdoctoral fellowship in human psychopharmacology at the National Institutes of Health and an addiction psychiatry fellowship at Yale University. Dr. Sloan's primary research interests are developing innovative new treatments for substance use disorders and exploring determinants of psychopharmacological response to drugs of misuse. He has obtained competitive research funding from the Canadian Institutes of Health Research, Health Canada, and the Centre for Addiction and Mental Health Discovery Fund and has received scientific prizes from the American Academy of Addiction Psychiatry and the National Institute on Alcohol Abuse and Alcoholism.

Article Link: Symptom-Triggered Alcohol Withdrawal Management Delivered Over Telemedicine

In this episode, Dr. Nicolas Garel joins the podcast to discuss findings from his new article in the September/October issue of the Journal of Addiction Medicine titled Increased Risks of Major Cardiac Adverse Events in Stimulant Use Disorder as Compared With Other Substance Use Disorders: A Propensity-score Matching Cohort Study.

Dr. Nicolas Garel is a psychiatrist and clinician-scientist at the Centre Hospitalier de l’Université de Montréal (CHUM). He is an assistant professor in the Department of Psychiatry at the Université de Montréal and adjunct professor in the Department of Psychiatry and Behavioral Sciences at Stanford University. Dr. Garel completed his medical degree at the Université de Montréal, followed by his psychiatry residency and clinician-scientist fellowship at McGill University, and later pursued advanced training in research and addiction medicine at Stanford University. His research program focuses on innovative interventions for treatment-resistant mood disorders and substance use disorders.

Article Link: Increased Risks of Major Cardiac Adverse Events in Stimulant Use Disorder as Compared With Other Substance Use Disorders: A Propensity-score Matching Cohort Study